Medibio Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medibio Ltd with three other
companies in this sector in Australia:
Pharmaust Limited
(2019
sales of 4.36 million Australian Dollars [US$2.88 million]
),
Noxopharm Ltd
(3.94 million Australian Dollars [US$2.60 million]
), and
Adalta Ltd
(3.59 million Australian Dollars [US$2.37 million]
).
Sales Analysis.
Medibio Ltd reported sales of A$4.13 million (US$2.73 million)
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 58.9%
versus 2018, when the company's sales were A$2.60 million.